Rapport Therapeutics (RAPP) earnings, Nov 4, 2026: EPS −18%, stock +1.9%
In brief
Rapport Therapeutics reported on Nov 4, 2026. Earnings per share changed −18% year over year, 30.2% above the estimate; revenue 0%. The stock opened with a +2.7% gap and closed the day +1.9% (Nov 4, 2026). The stock is now 55.2% below its 52-week high, −9.4% over 12 months. Next report: Mar 16, 2027.
EPS vs estimate+30.2%
EPS, YoY−18%
Revenue, YoY0%
Gap · day+2.7% · +1.9%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 5, 2026 | −1.8% | +0.6% |
| Nov 4, 2026 | +2.7% | +1.9% |
Next-quarter estimates, ratings and the RAPP chart are in the terminal.
Open the terminalFAQ
When is Rapport Therapeutics's next earnings report?
Mar 16, 2027. The date comes from daily data and is corrected if the company moves it.
How did Rapport Therapeutics stock react to the report?
Opening gap +2.7%, day's result +1.9%.
Did Rapport Therapeutics's earnings grow?
Earnings per share fell 18% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.